Table 7 Patient characteristics focusing on functional CMR results
MD | Normal LV and RV function | Impaired LV and/or RV function | p value | |
|---|---|---|---|---|
N = 63 | N = 31 | N = 32 | ||
Male, n (%) | 63 (100) | 31 (100) | 32 (100) | 1.00 |
Age, years | 31 ± 15 | 27 ± 15 | 34 ± 15 | 0.11 |
BMD, n (%) | 51 (81) | 26 (84) | 25 (78) | 0.75 |
BMI, kg/m2 | 24 ± 4 | 24 ± 5 | 24 ± 3 | 0.72 |
Skeletal muscle status 0/1/2/3, n (%) | 2 (3)/43 (68)/13 (21)/5 (8) | 2 (7)/23 (74)/5 (16)/1 (3) | 20 (63)/8 (25)/4 (13)/0 (0) | 0.20 |
ACE inhibitor, n (%) | 16 (25) | 2 (7) | 14 (44) | 0.001 |
Beta-blocker, n (%) | 14 (22) | 4 (13) | 10 (31) | 0.13 |
CK, U/L | 1226 (653–2424) | 1250 (652–3043) | 1221 (727–2291) | 0.86 |
Elevated hs-Trop, n (%)a | 30 (48) | 8 (26) | 22 (67) | 0.001 |
Elevated NT-proBNP, n (%)b | 3 (5) | 0 (0) | 3 (9) | 0.24 |